This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is completed in the United Kingdom, in Ireland, in Sweden, .... It is testing Pregabalin (300-600 mg/day) and Venlafaxine XR (75-225 mg/day) for Anxiety.
This study is ongoing in the United Kingdom, in Germany, and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase for Schizophrenia.
This study is completed in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
This study is ongoing in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.